Clinical Trials in Tennessee

Showing 13641-13660 of 20,239 trials

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

NCT02138812

Determine the safety, tolerability, maximum tolerated dose (MTD), and recommended Phase II dose (RP2D) of BAY1161909 in combination with paclitaxel in subjects with advanced malignancies.

Medical Oncology

Bayer69 participantsStarted May 2014

Santa Monica, California, United States • New Haven, Connecticut, United States • Boston, Massachusetts, United States +3 more locations

COMPLETEDPhase 429 miles

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

NCT00084136

This study compared 3 different three-drug combinations in HIV infected individuals starting their first HIV treatment regimens. Participants were recruited from resource-limited areas in Africa, Asia, South America, Haiti, and also from the United States. The study hypothesis was each of the once daily combinations (PI based, or NNRTI based) would not have inferior efficacy compared to the twice daily NNRTI based combination.

HIV Infections

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1,571 participantsStarted May 2005

Los Angeles, California, United States • Los Angeles, California, United States • Torrance, California, United States +39 more locations

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Find Trials by Condition in Tennessee

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma

Gastric Electrical Stimulation (GES) for the Treatment of Obesity

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Sevelamer for Reducing Endotoxemia and Immune Activation

A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Do Consumer Providers Enhance Recovery?

Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer

Post-Market Study of the Modular Revision Hip System

A Study of Axitinib in Advanced Carcinoid Tumors

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies